EXCLUSIVE: Oprah Winfrey Decides To End Legendary Show, Plans To Move To Italy: “I CAN’T LIVE IN THE U.S. FOR THE NEXT 4 YEARS AND BREATHE THE SAME AIR AS ELON MUSK.”

Oprah Winfrey announced she was leaving WeightWatchers on Thursday and giving away all her stock – a move that follows the TV talk queen revealing that her recent dramatic weight loss was due to taking new weight-loss drugs.

A statement from Winfrey issued by the company said that the talkshow host, a public face for WeightWatchers since 2015, would donate all her shares in the company to the National Museum of African American History and Culture “to eliminate any perceived conflict of interest around her taking weight-loss medications”.

According to the FDA, 39% of Americans are obese, and another 31% overweight and 8% are severely obese. “In general, rates of obesity are higher for Black and Hispanic women, for Hispanic men, in the South and Midwest, in nonmetropolitan counties, and tend to increase with age,” the administration says.

According to JP Morgan, the market for GLP-1 drugs, which can cost $1,000 a month, will exceed $100bn by 2030. Total GLP-1 users in the US may number 30 million by 2030 – or about 9% of the overall population.

“The increasing appetite for obesity drugs will have myriad implications, boosting sectors such as biotech and creating headwinds for industries such as food and beverage,” the bank’s report said.